Malaysia's National Pharmaceutical Regulatory Agency (NPRA) has announced1 the release of the third edition, eighth revision of the Drug Registration Guidance Document (DRGD)2 on July 23, 2024, which will come into effect on July 31, 2024.
Malaysia's National Pharmaceutical Regulatory Agency (NPRA) has announced1 the release of the third edition, eighth revision of the Drug Registration Guidance Document (DRGD)2 on July 23, 2024, which will come into effect on July 31, 2024.